Anti-Human IL23A Recombinant Antibody(Tildrakizumab)
-
产品编号
YR1295
-
别名
科研级 Tildrakizumab ( 替曲吉珠单抗 ), Anti-IL23A Recombinant Antibody, Research Grade Tildrakizumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1295 |
| Alias | 科研级 Tildrakizumab ( 替曲吉珠单抗 ), Anti-IL23A Recombinant Antibody, Research Grade Tildrakizumab |
| Size | 1mg, 5mg |
| Molecular Name | Tildrakizumab |
| CAS Number | 1326244-10-3 |
| Molecular Weight | 144.4 kDa |
| Target | IL23A[Homo sapiens] |
| Host | Mouse |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Tildrakizumab (trade name Ilumya (US)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. It is approved for the treatment of adult patients with moderate-to-severe plaque psoriasis in the United States and the European Union. |
| Application | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
| Remarks | This product is for research use only. |
0